Compare Bank Danamon Indonesia Tbk (BDMN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Danamon Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Danamon Indonesia Tbk trades at Rp4,150 (market cap 40.06T, 1.96M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Danamon Indonesia Tbk is far larger — about 243.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Danamon Indonesia Tbk is more actively traded (1.96M versus 214.9K). Which is the better fit depends on your goals.
| BDMN | OBAT | |
|---|---|---|
Market Cap | 40.06T | 164.65B |
Volume | 1.96M | 214.9K |
Lot | 19.62K | 2.15K |
Turnover | 8.11B | 51.97M |
Average Price | 4,134.3 | 241.85 |
Value | 8.11B | 51.97M |
Indicative Equilibrium Price | 4,150 | 240 |
Indicative Equilibrium Volume | 390 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Danamon Indonesia Tbk
Bank Danamon (the Bank) domiciled in Jakarta, was established on July 16, 1956, based on the notarial deed No. 134 of Meester Raden Soedja, S.H. The Bank received its permit as a commercial bank the following September 1956, and became a foreign exchange bank in November 1988. During the Asian Financial crisis of 1997, Bank Danamon ran into a liquidity insolvency and was taken over by the government of Indonesia in April 1998, which placed in the care of the Indonesian Bank Restructuring Agency (IBRA) to be included in the bank recapitalization and merger programs. Following a third rights issue by Bank Danamon and the subsequent merging of Bank PDFCI into the Bank on December 30, 1999; the racapitalizaton of Bank Danamon which increased its statutory capital To Rp 10 trillion on May 17, 2000; and the merging of eight private banks (Bank Jaya, Bank Tiara Asia, Bank Pos Nusntara, Bank Rama, Bank Tamara, Bank Nusa Nasional, Bank Duta and Bank Bank Risjad Salim International) into Bank Danamon on June 30, 2000; Bank Danamon re-emerged as one of Indonesia’s four designated core banks along with Bank Central Asia in the private sector, and with Bank andiri and Bank BNI in the Public sector.
Read more on BDMN →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
